Double maintains 1 strategies that include TVTX - Travere Therapeutics, Inc.
Yahoo
SAN DIEGO, May 15, 2025--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for traditional approval of FILSPARI (sparsentan) for the treatment of focal segmental glomerulosclerosis (FSGS). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of January 13, 2026, and has indicated that it is currently planning to hold an advisory committee meeting to discu
Yahoo
– Company reports $3.4 million in YCANTH revenue, reflective of increasing demand, following the dispensing of more than 10,000 applicator units in the quarter, the most in company history and a 16.7% growth over Q4’24 – – Late-stage pipeline continues to advance with completion of end-of-Phase 2 meeting with Food and Drug Administration for VP-315, Verrica’s candidate for basal cell carcinoma, and continued advancement towards initiation of global Phase 3 program in common warts (VP-102/YCANTH)
Yahoo
SAN DIEGO, May 12, 2025--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on May 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants to six new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 35,900 shares of its common stock. These inducement RSUs are subject to the terms of Travere’s 2018 Equity Incentive Plan ("2018 Plan") but were granted outside of the 2018 Plan and were granted as induce
Yahoo
SAN DIEGO, May 07, 2025--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that company management will participate in the following upcoming investor conferences:
Finnhub
Presenter SpeechJason Zemansky [Audio Gap] And I'm currently very pleased to have join me on stage, Eric Dube and Peter Heerma from Travere Therapeutics. Eric is going to start with a presentation,...
Yahoo
As you might know, Travere Therapeutics, Inc. ( NASDAQ:TVTX ) just kicked off its latest quarterly results with some...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -34.38% | $140.49M | 0.59% |
VIXY | -32.76% | $109.64M | 0.85% |
BTAL | -25.69% | $361.41M | 1.43% |
IVOL | -19.75% | $353.94M | 1.02% |
XHLF | -18.21% | $1.46B | 0.03% |
TPMN | -18.14% | $31.54M | 0.65% |
GBIL | -17.39% | $6.17B | 0.12% |
SPTS | -16.26% | $5.76B | 0.03% |
BILS | -15.75% | $3.96B | 0.1356% |
UTWO | -14.70% | $387.71M | 0.15% |
BIL | -14.64% | $45.95B | 0.1356% |
CLIP | -14.34% | $1.50B | 0.07% |
IBTG | -13.58% | $1.88B | 0.07% |
XONE | -13.54% | $603.24M | 0.03% |
FXY | -13.30% | $838.61M | 0.4% |
GSST | -12.34% | $857.21M | 0.16% |
VGSH | -11.91% | $22.38B | 0.03% |
UNG | -10.97% | $371.83M | 1.06% |
IBTH | -10.88% | $1.53B | 0.07% |
BILZ | -10.86% | $876.85M | 0.14% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 46.78% | $4.85B | 0.35% |
PTH | 42.60% | $96.56M | 0.6% |
IBB | 41.28% | $5.22B | 0.45% |
IWMY | 39.30% | $109.62M | 1.02% |
XDTE | 38.43% | $382.21M | 0.95% |
XPH | 38.03% | $136.58M | 0.35% |
PBE | 37.42% | $214.12M | 0.58% |
IWC | 37.37% | $766.88M | 0.6% |
KJUL | 37.10% | $113.35M | 0.79% |
IWO | 36.84% | $11.36B | 0.24% |
GNOM | 36.69% | $40.65M | 0.5% |
ISPY | 36.62% | $784.51M | 0.55% |
QQQJ | 36.13% | $610.08M | 0.15% |
ACIO | 36.07% | $1.84B | 0.79% |
PVAL | 35.96% | $2.82B | 0.56% |
SUSA | 35.68% | $3.48B | 0.25% |
PSFF | 35.46% | $444.17M | 0.75% |
IWM | 35.36% | $63.95B | 0.19% |
NANC | 35.33% | $207.08M | 0.74% |
VTWO | 35.27% | $12.07B | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
XNCR | 42.40% | $583.60M | -63.49% | 0.00% |
RLAY | 41.64% | $478.33M | -57.14% | 0.00% |
CRNX | 41.54% | $2.92B | -39.88% | 0.00% |
COGT | 39.45% | $543.09M | -36.14% | 0.00% |
KYMR | 38.05% | $1.95B | -15.67% | 0.00% |
DNLI | 37.84% | $2.06B | -30.04% | 0.00% |
ACLX | 36.91% | $3.22B | +10.72% | 0.00% |
GLW | 36.45% | $40.77B | +35.15% | 2.35% |
NCLH | 36.37% | $8.53B | +20.14% | 0.00% |
RCKT | 36.18% | $724.54M | -71.26% | 0.00% |
ATXS | 35.97% | $225.17M | -57.69% | 0.00% |
RL | 35.68% | $16.62B | +62.02% | 1.23% |
GLOB | 35.57% | $5.85B | -25.26% | 0.00% |
RVMD | 35.42% | $7.35B | +1.15% | 0.00% |
BHVN | 35.40% | $1.62B | -58.86% | 0.00% |
CUK | 35.30% | $3.02B | +53.06% | 0.00% |
SPGI | 35.15% | $159.26B | +18.55% | 0.71% |
CCL | 34.93% | $30.18B | +54.36% | 0.00% |
ZD | 34.81% | $1.39B | -42.74% | 0.00% |
RCL | 34.56% | $67.92B | +75.07% | 0.68% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
FMHI | -0.01% | $757.44M | 0.7% |
BSSX | 0.01% | $75.11M | 0.18% |
MMIN | 0.05% | $469.53M | 0.3% |
TDTF | -0.11% | $788.24M | 0.18% |
SCHP | 0.11% | $12.81B | 0.03% |
UCON | -0.14% | $3.06B | 0.85% |
MBB | 0.16% | $37.74B | 0.04% |
FLCB | 0.17% | $2.52B | 0.15% |
BSCR | -0.20% | $3.49B | 0.1% |
NYF | -0.21% | $875.13M | 0.25% |
GOVI | -0.26% | $870.08M | 0.15% |
BKAG | 0.28% | $1.86B | 0% |
IBTF | -0.32% | $2.12B | 0.07% |
IBDS | -0.38% | $3.01B | 0.1% |
MTBA | 0.40% | $1.56B | 0.17% |
MLN | -0.41% | $532.71M | 0.24% |
EAGG | 0.48% | $3.77B | 0.1% |
FLMI | 0.48% | $649.76M | 0.3% |
BSCS | -0.49% | $2.55B | 0.1% |
JMBS | 0.53% | $5.40B | 0.22% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KDP | 0.06% | $45.55B | -1.76% | 2.70% |
DUK | 0.16% | $90.12B | +12.74% | 3.61% |
ALHC | -0.18% | $2.95B | +113.16% | 0.00% |
CODX | -0.21% | $10.29M | -73.23% | 0.00% |
KOF | 0.21% | $4.80B | -6.62% | 4.51% |
FIZZ | -0.21% | $4.16B | +0.40% | 0.00% |
SIRI | 0.23% | $7.56B | -26.69% | 3.73% |
SO | -0.23% | $96.04B | +10.08% | 3.29% |
MCK | -0.23% | $88.42B | +27.17% | 0.39% |
CL | 0.28% | $72.64B | -5.18% | 2.25% |
PRPO | 0.28% | $10.84M | +15.14% | 0.00% |
TME | 0.31% | $11.45B | +5.62% | 1.90% |
DRD | 0.31% | $1.23B | +63.69% | 2.01% |
FIGS | -0.32% | $754.24M | -20.00% | 0.00% |
DKL | -0.38% | $2.18B | +4.94% | 10.75% |
LU | 0.41% | $2.45B | -35.82% | 0.00% |
CI | -0.44% | $82.51B | -8.96% | 1.84% |
GIS | 0.45% | $29.79B | -23.81% | 4.42% |
WOOF | 0.46% | $879.15M | +28.86% | 0.00% |
CHD | 0.54% | $23.29B | -11.36% | 1.23% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LITB | -16.46% | $21.28M | -72.45% | 0.00% |
CBOE | -11.80% | $22.95B | +20.67% | 1.12% |
KR | -11.68% | $44.68B | +24.17% | 1.89% |
K | -11.05% | $28.49B | +32.17% | 2.77% |
ED | -10.08% | $36.75B | +5.26% | 3.28% |
GORV | -9.99% | $15.42M | -96.17% | 0.00% |
SEG | -9.90% | $239.93M | -26.61% | 0.00% |
CNC | -9.15% | $29.89B | -22.14% | 0.00% |
KLG | -9.13% | $1.55B | -16.04% | 3.59% |
CME | -8.84% | $98.74B | +28.80% | 3.84% |
VSTA | -8.24% | $326.82M | +11.64% | 0.00% |
FMTO | -8.06% | $45.74M | -99.96% | 0.00% |
WBA | -7.82% | $9.67B | -39.04% | 6.69% |
HEES | -7.56% | $3.52B | +99.54% | 1.15% |
STG | -7.38% | $27.05M | -37.35% | 0.00% |
VSA | -7.25% | $7.04M | -49.24% | 0.00% |
MOH | -6.80% | $17.02B | -8.99% | 0.00% |
AWK | -6.80% | $27.37B | +4.54% | 2.22% |
ACI | -5.93% | $12.61B | +4.78% | 2.47% |
NUS | -5.64% | $369.12M | -46.10% | 3.20% |
Current Value
$18.011 Year Return
Current Value
$18.011 Year Return